Amalgamated Bank’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.87M Sell
16,848
-80
-0.5% -$44.9K 0.06% 257
2026
Q1
$9.51M Sell
16,928
-595
-3% -$382K 0.07% 222
2025
Q4
$11.9M Sell
17,523
-695
-4% -$473K 0.09% 176
2025
Q3
$11.6M Buy
18,218
+192
+1% +$117K 0.08% 179
2025
Q2
$9.67M Buy
18,026
+711
+4% +$340K 0.07% 199
2025
Q1
$7.27M Buy
17,315
+419
+2% +$182K 0.06% 249
2024
Q4
$6.99M Sell
16,896
-684
-4% -$300K 0.06% 268
2024
Q3
$8.88M Sell
17,580
-172
-1% -$83.6K 0.07% 213
2024
Q2
$8.65M Sell
17,752
-167
-0.9% -$83.8K 0.07% 204
2024
Q1
$9.68M Sell
17,919
-3,120
-15% -$1.71M 0.08% 190
2023
Q4
$11.7M Sell
21,039
-1,512
-7% -$710K 0.09% 179
2023
Q3
$9.86M Sell
22,551
-1,205
-5% -$601K 0.08% 200
2023
Q2
$11.9M Buy
23,756
+910
+4% +$436K 0.1% 169
2023
Q1
$11.4M Buy
22,846
+255
+1% +$122K 0.1% 176
2022
Q4
$9.22M Buy
22,591
+165
+0.7% +$64K 0.08% 217
2022
Q3
$7.31M Buy
22,426
+251
+1% +$92.2K 0.07% 255
2022
Q2
$7.78M Sell
22,175
-1,961
-8% -$800K 0.07% 236
2022
Q1
$13.2M Buy
24,136
+1,008
+4% +$530K 0.1% 153
2021
Q4
$15.2M Buy
23,128
+3,698
+19% +$2.32M 0.11% 145
2021
Q3
$12.1M Sell
19,430
-897
-4% -$603K 0.1% 156
2021
Q2
$12.8M Buy
20,327
+15,144
+292% +$8.36M 0.1% 153
2021
Q1
$2.54M Sell
5,183
-248
-5% -$124K 0.1% 169
2020
Q4
$2.71M Sell
5,431
-26
-0.5% -$11.6K 0.1% 156
2020
Q3
$2.15M Sell
5,457
-160
-3% -$59.2K 0.09% 174
2020
Q2
$1.85M Sell
5,617
-8,542
-60% -$2.47M 0.09% 188
2020
Q1
$3.43M Sell
14,159
-460
-3% -$120K 0.08% 198
2019
Q4
$3.82M Buy
14,619
+496
+4% +$131K 0.07% 248
2019
Q3
$3.84M Buy
14,123
+2,853
+25% +$794K 0.08% 224
2019
Q2
$3.1M Sell
11,270
-1,624
-13% -$400K 0.07% 250
2019
Q1
$2.88M Buy
12,894
+273
+2% +$56.4K 0.07% 258
2018
Q4
$2.35M Sell
12,621
-378
-3% -$77.5K 0.07% 267
2018
Q3
$3.25M Sell
12,999
-399
-3% -$96.9K 0.08% 225
2018
Q2
$2.92M Buy
13,398
+745
+6% +$154K 0.07% 240
2018
Q1
$2.42M Buy
12,653
+1,139
+10% +$210K 0.06% 298
2017
Q4
$1.8M Buy
11,514
+1,006
+10% +$158K 0.05% 405
2017
Q3
$1.63M Buy
10,508
+212
+2% +$33.5K 0.05% 381
2017
Q2
$1.66M Sell
10,296
-4,092
-28% -$665K 0.05% 357
2017
Q1
$2.23M Sell
14,388
-2,767
-16% -$381K 0.11% 163
2016
Q4
$2.01M Buy
17,155
+1,648
+11% +$188K 0.09% 201
2016
Q3
$1.75M Sell
15,507
-16
-0.1% -$1.69K 0.1% 180
2016
Q2
$1.72M Buy
15,523
+4,042
+35% +$347K 0.1% 189
2016
Q1
$899K Buy
11,481
+863
+8% +$62.1K 0.09% 246
2015
Q4
$774K Sell
10,618
-743
-7% -$53K 0.1% 223
2015
Q3
$844K Buy
11,361
+156
+1% +$11.2K 0.09% 238
2015
Q2
$719K Buy
11,205
+3
+0% +$208 0.07% 335
2015
Q1
$865K Buy
11,202
+378
+3% +$29.4K 0.11% 224
2014
Q4
$802K Sell
10,824
-804
-7% -$56.4K 0.13% 183
2014
Q3
$685K Buy
11,628
+138
+1% +$8.72K 0.1% 229
2014
Q2
$767K Sell
11,490
-1,154
-9% -$73.4K 0.12% 189
2014
Q1
$767K Sell
12,644
-92
-0.7% -$5.48K 0.13% 164
2013
Q4
$677K Buy
+12,736
New +$670K 0.12% 199

Other funds holding IDXX

Amalgamated Bank's IDXX Position: Q2 2026 in Review

Amalgamated Bank reduced its Idexx Laboratories (IDXX) stake by 0.47% in Q2 2026, selling an estimated $44.9K and leaving 16,848 shares worth $8.87M. The position accounts for 0.06% of the portfolio, ranked #257.

Amalgamated Bank first reported a position in IDXX in Q4 2013 and has held it in 51 quarters since. The position peaked at $15.2M in Q4 2021. 715 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Amalgamated Bank held 16,848 shares of Idexx Laboratories worth $8.87M as of Q2 2026.
  • Amalgamated Bank sold 80 Idexx Laboratories shares in Q2 2026, an estimated $44.9K.
  • Idexx Laboratories made up 0.06% of Amalgamated Bank's portfolio in Q2 2026, its #257 holding.
  • Amalgamated Bank first reported a position in Idexx Laboratories in Q4 2013 and has held it in 51 quarters since.
  • Amalgamated Bank's Idexx Laboratories position peaked at $15.2M in Q4 2021.
  • 715 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.